We are live on ! Find out more
SIAU

SB Investment Advisers (UK) Portfolio holdings

AUM $7.73B
1-Year Est. Return 2.35%
This Fund
S&P 500
This Quarter Est. Return
-17.68%
1 Year Est. Return
-2.35%
3 Year Est. Return
+51.59%
5 Year Est. Return
-28.22%
10 Year Est. Return
AUM
$9.99B
AUM Growth
-$3.26B
Cap. Flow
-$731M
Cap. Flow %
-7.31%
Top 10 Hldgs %
100%
Holding
10
New
Increased
Reduced
4
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$472M
2
COMP icon
Compass
COMP
+$180M
3
YMM icon
Full Truck Alliance
YMM
+$58.2M
4
VIR icon
Vir Biotechnology
VIR
+$21.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 69.1%
2 Technology 20.63%
3 Healthcare 6.77%
4 Real Estate 2.65%
5 Utilities 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPNG icon
1
Coupang
CPNG
$29.2B
$6.83B 68.34%
289,542,259
GRAB icon
2
Grab
GRAB
$15B
$2B 20.06%
401,796,672
ROIV icon
3
Roivant Sciences
ROIV
$26.1B
$356M 3.56%
16,413,603
-23,901,524
-59% -$472M
COMP icon
4
Compass
COMP
$9.45B
$265M 2.65%
25,062,973
-19,698,164
-44% -$180M
RLAY icon
5
Relay Therapeutics
RLAY
$4.23B
$236M 2.36%
27,904,963
NRGV icon
6
Energy Vault
NRGV
$620M
$85.4M 0.85%
18,535,631
VIR icon
7
Vir Biotechnology
VIR
$1.51B
$79.1M 0.79%
13,116,977
-3,567,064
-21% -$21.2M
AUR icon
8
Aurora
AUR
$13.8B
$76.1M 0.76%
19,811,760
YMM icon
9
Full Truck Alliance
YMM
$9.95B
$56.6M 0.57%
5,272,390
-4,852,722
-48% -$58.2M
DNA icon
10
Ginkgo Bioworks
DNA
$517M
$5.08M 0.05%
610,729

Similar funds

SB Investment Advisers (UK)'s Q4 2025 Portfolio in Review

As of Q4 2025, SB Investment Advisers (UK) held 10 positions worth $9.99B, down 25% from $13.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SB Investment Advisers (UK) withdrew a net $731M in Q4 2025, reducing 4 holdings. Its largest reduction was Roivant Sciences, cutting an estimated $472M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 69% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

  • SB Investment Advisers (UK)'s biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $472M.
  • SB Investment Advisers (UK)'s ten largest holdings make up 100% of its $9.99B portfolio in Q4 2025.
  • SB Investment Advisers (UK) opened 0 new positions and closed 0 in Q4 2025.
  • SB Investment Advisers (UK)'s portfolio value fell 25% quarter-over-quarter to $9.99B.

Based on SB Investment Advisers (UK)'s 13F filing for Q4 2025, filed 18 Feb 2026.